EAF2 and prostate carcinoma: p53 suppresses the activity of the TSP-1 promoter and downregulates the expression of TSP-1 in prostate cancer cells (Kwak et al., 2002); however, this suppression would be significantly alleviated by co-transfection of EAF2 with p53 in PC-3 cells.